Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2008-05-06
2008-05-06
Eyler, Yvonne (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C514S415000, C514S634000, C548S483000
Reexamination Certificate
active
07368605
ABSTRACT:
Formula (I) compoundsare described where the groups are as identified in the text, and their use as medicines, particularly as anti-diabetes, serum glucose-lowering and anti-obesity agents. They are useful for the prophylaxis and treatment of diabetes, particularly type 2 diabetes, and its complications, syndrome X, the various forms of insulin resistance, and hyperlipidaemias, as well as for the treatment of obesity.
REFERENCES:
patent: 4731383 (1988-03-01), Erczi et al.
patent: 93/03714 (1993-03-01), None
patent: WO 97/23203 (1997-07-01), None
International Search Report for PCT/IT03/00792 dated Apr. 26, 2004.
Wilkinson-Berka, et al.,ALT-946 and Aminoguanidine, Inhibitors of Advanced Glycation, Improve Severe Nephropathy in the Diabetic Transgenic(mREN-2)27 Rat, Diabetes, vol. 51, Nov. 2002, XP-002276482, pp. 3283-3289.
Botta Maurizio
Corelli Pederico
Giannessi Fabio
Pessotto Pompeo
Tassoni Emanuela
Cutliff Yate′ K
Eyler Yvonne
Nixon & Vanderhye P.C.
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
LandOfFree
Variously substituted derivatives of guanidine, and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Variously substituted derivatives of guanidine, and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Variously substituted derivatives of guanidine, and their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2809534